149 related articles for article (PubMed ID: 38287511)
101. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.
Nagarsheth NB; Norberg SM; Sinkoe AL; Adhikary S; Meyer TJ; Lack JB; Warner AC; Schweitzer C; Doran SL; Korrapati S; Stevanović S; Trimble CL; Kanakry JA; Bagheri MH; Ferraro E; Astrow SH; Bot A; Faquin WC; Stroncek D; Gkitsas N; Highfill S; Hinrichs CS
Nat Med; 2021 Mar; 27(3):419-425. PubMed ID: 33558725
[TBL] [Abstract][Full Text] [Related]
102. Local delivery of accutox
Bikorimana JP; El-Hachem N; Abusarah J; Gonçalves MP; Farah R; Mandl GA; Talbot S; Beaudoin S; Stanga D; Plouffe S; Rafei M
J Transl Med; 2024 Jun; 22(1):532. PubMed ID: 38831284
[TBL] [Abstract][Full Text] [Related]
103. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
104. Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumours.
Bubenik J
Curr Cancer Drug Targets; 2008 May; 8(3):180-6. PubMed ID: 18473731
[TBL] [Abstract][Full Text] [Related]
105. An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
Bikorimana JP; Abusarah J; Gonçalves M; Farah R; Saad W; Talbot S; Stanga D; Beaudoin S; Plouffe S; Rafei M
Cancer Sci; 2024 Apr; 115(4):1102-1113. PubMed ID: 38287511
[TBL] [Abstract][Full Text] [Related]
106. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
107. SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model.
Sharma RK; Srivastava AK; Yolcu ES; MacLeod KJ; Schabowsky RH; Madireddi S; Shirwan H
Vaccine; 2010 Aug; 28(36):5794-802. PubMed ID: 20603135
[TBL] [Abstract][Full Text] [Related]
108. A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
Han X; Gao Z; Cheng Y; Wu S; Chen J; Zhang W
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895145
[TBL] [Abstract][Full Text] [Related]
109. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
Yang Y; Che Y; Zhao Y; Wang X
Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204
[TBL] [Abstract][Full Text] [Related]
110. Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives.
Mo Y; Ma J; Zhang H; Shen J; Chen J; Hong J; Xu Y; Qian C
Front Cell Infect Microbiol; 2022; 12():909223. PubMed ID: 35860379
[TBL] [Abstract][Full Text] [Related]
111. Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.
Bikorimana JP; Salame N; Beaudoin S; Balood M; Crosson T; Abusarah J; Talbot S; Löbenberg R; Plouffe S; Rafei M
Cell Rep Med; 2022 Mar; 3(3):100534. PubMed ID: 35492876
[TBL] [Abstract][Full Text] [Related]
112. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances.
Zhang J; Fan J; Skwarczynski M; Stephenson RJ; Toth I; Hussein WM
Int J Nanomedicine; 2022; 17():869-900. PubMed ID: 35241913
[TBL] [Abstract][Full Text] [Related]
113. Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.
Abusarah J; Khodayarian F; El-Hachem N; Salame N; Olivier M; Balood M; Roversi K; Talbot S; Bikorimana JP; Chen J; Jolicoeur M; Trudeau LE; Kamyabiazar S; Annabi B; Robert F; Pelletier J; El-Kadiry AE; Shammaa R; Rafei M
Cell Rep Med; 2021 Dec; 2(12):100455. PubMed ID: 35028603
[TBL] [Abstract][Full Text] [Related]
114. Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16
Salomon N; Selmi A; Grunwitz C; Kong A; Stanganello E; Neumaier J; Petschenka J; Diken M; Kreiter S; Türeci Ö; Sahin U; Vascotto F
Cancer Immunol Immunother; 2022 Aug; 71(8):1975-1988. PubMed ID: 34971406
[TBL] [Abstract][Full Text] [Related]
115. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.
Kamolratanakul S; Pitisuttithum P
Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960159
[TBL] [Abstract][Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]